Neil James Clendeninn
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Neil James Clendeninn
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.
25
| Subsidiary | Pharmaceuticals: Major | 25 |
OncoGenex Technologies, Inc.
 OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada.
7
| Extinct | Pharmaceuticals: Major | 7 |
| Public Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Neil James Clendeninn tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO General Counsel Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal General Counsel Director of Finance/CFO | |
| ACHIEVE LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Association of Professional Engineers & Geoscientists of BC | Corporate Officer/Principal Corporate Officer/Principal | ||
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
| Genetic Systems Corp. | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | ||
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Founder | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Doctorate Degree Graduate Degree | |
| SENOMYX INC. | Food: Specialty/Candy | Chief Executive Officer Human Resources Officer | |
The Conference Board, Inc.
 The Conference Board, Inc. Miscellaneous Commercial ServicesCommercial Services The Conference Board, Inc. is a membership organization working for the public interests. It creates and disseminates knowledge about management and the marketplace to help businesses in their performance and to better serve the society. The firm publishes information and analysis, makes economics-based forecasts and assesses trends, and facilitates learning by creating communities of interest that bring together senior executives from around the world. The company was founded in 1916 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
| University of California, Irvine | College/University | Doctorate Degree Undergraduate Degree | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Purdue University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Graduate Degree | |
| CANFOR CORPORATION | Forest Products | President Chief Executive Officer | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Brown University | College/University | Graduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director/Board Member | |
| CUMBERLAND PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The American Society for Cell Biology | Corporate Officer/Principal | ||
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| Vancouver General Hospital | Corporate Officer/Principal | ||
| University of California Irvine School of Medicine | College/University | Masters Business Admin | |
| NeuroSpheres Ltd. | Chief Operating Officer | ||
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Canada | 11 |
| Francia | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Miscellaneous | 2 |
| Consumer Non-Durables | 2 |
Posizioni
| Corporate Officer/Principal | 91 |
| Director/Board Member | 71 |
| Undergraduate Degree | 32 |
| President | 25 |
| Director of Finance/CFO | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| James F. Shepard | 18 |
| Scott Daniel Cormack | 15 |
| David Szekeres | 15 |
| Michael J. Kamdar | 13 |
| Edgardo Baracchini | 13 |
| James Shepherd | 13 |
| Cindy Jacobs | 12 |
| Stephen Worland | 12 |
| Barry Quart | 12 |
| Mark Brian Anderson | 11 |
| Christian Waage | 11 |
| Paul G. Marshall | 10 |
| James R. Thomas | 10 |
| Martin Mattingly | 10 |
| Karen Potts | 9 |
- Borsa valori
- Insiders
- Neil James Clendeninn
- Connessioni Società
